Multigene measurable residual disease assessment improves AML relapse risk stratification in autologous hematopoietic cell transplantation

We report here the largest study to date of adult AML patients tested for measurable residual disease (MRD) at the time of autologous hematopoietic cell transplantation (auto-HCT). Seventy-two adult patients transplanted between 2004–2013 at a single academic medical center (UCSF) were eligible for...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biol Blood Marrow Transplant
Hlavní autoři: Mulé, Matthew P., Mannis, Gabriel N., Wood, Brent L., Radich, Jerald P., Hwang, Jimmy, Ramos, Nestor R., Andreadis, Charalambos, Damon, Lloyd, Logan, Aaron C., Martin, Thomas G., Hourigan, Christopher S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5072749/
https://ncbi.nlm.nih.gov/pubmed/27544285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.08.014
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky